12-2593229-G-A

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000719.7(CACNA1C):​c.2547G>A​(p.Glu849Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.484

Publications

2 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 12-2593229-G-A is Benign according to our data. Variant chr12-2593229-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 527070.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.484 with no splicing effect.
BS2
High AC in GnomAdExome4 at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.2637G>A p.Glu879Glu synonymous_variant Exon 19 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.2712G>A p.Glu904Glu synonymous_variant Exon 20 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.2637G>A p.Glu879Glu synonymous_variant Exon 19 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.2637G>A p.Glu879Glu synonymous_variant Exon 19 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.2637G>A p.Glu879Glu synonymous_variant Exon 19 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.2637G>A p.Glu879Glu synonymous_variant Exon 19 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.2622G>A p.Glu874Glu synonymous_variant Exon 20 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.2622G>A p.Glu874Glu synonymous_variant Exon 20 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.2538G>A p.Glu846Glu synonymous_variant Exon 19 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.2547G>A p.Glu849Glu synonymous_variant Exon 19 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*1154G>A non_coding_transcript_exon_variant Exon 17 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*1154G>A 3_prime_UTR_variant Exon 17 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152226
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000161
AC:
4
AN:
248576
AF XY:
0.0000222
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000355
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000753
AC:
11
AN:
1461362
Hom.:
0
Cov.:
31
AF XY:
0.00000963
AC XY:
7
AN XY:
726914
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86124
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53384
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000630
AC:
7
AN:
1111742
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152226
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68024
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Mar 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 17, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
6.7
DANN
Benign
0.53
PhyloP100
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759093479; hg19: chr12-2702395; API